COVID-19 infection originated in Wuhan, China in December 2019 and crippled human
health globally in no time. The public health emergency required urgent efforts to develop …

The numbers of cases and deaths from coronavirus disease 2019 (COVID-19) are
continuously increasing. Many people are concerned about the efficacy and safety of the …

The development of safe, effective, affordable vaccines against COVID-19 remains the
cornerstone to mitigating this pandemic. Early in December 2020, multiple research groups …

Background: The adverse events reported from the COVID-19 mRNA vaccines have varied
from very mild, such as pain near the vaccination site, to more severe, with occasional …

Background: Optimization of COVID-19 vaccination rate among healthcare personnel is of
utmost priority to secure provision of uninterrupted care and to protect the most vulnerable …

Introduction COVID-19 vaccination seems to be the most pertinent pharmacologic public
health measure to control the pandemic. Reactogenicity symptoms were frequent in vaccine …

Importance Little is known about the factors associated with COVID-19 vaccine adverse
effects in a real-world population. Objective To evaluate factors potentially associated with …

Conventional vaccines have been widely studied, along with their risk of causing allergic
reactions. These generally consist of mild local reactions and only rarely severe …

Τhe most promising approach of fighting COVID-19 and restraining the course of this
pandemic is indisputably the universal vaccination of the population with safe and effective …

Abstract Background/Aim Pfizer-BioNTech, Moderna, and Johnson & Johnson's Janssen are
the 3 COVID-19 vaccines authorized for emergency use in the United States. This study …